Use este identificador para citar ou linkar para este item: http://hdl.handle.net/1843/53961
Tipo: Artigo de Periódico
Título: Bovine milk extracellular vesicles are osteoprotective by increasing osteocyte numbers and targeting RANKL/OPG system in experimental models of bone loss
Autor(es): Marina Chaves de Oliveira
Bartijn Pieters
Polianna B. Guimarães
Letícia F. Duffles
Joyce Elisa Heredia
Ana Letícia Malheiros Silveira
Amanda C. C. Oliveira
Mauro Martins Teixeira
Adaliene Versiani Matos Ferreira
Tarcilia A Silva
Fons Van De Loo
Soraia Macari
Resumo: Studying effects of milk components on bone may have a clinical impact as milk is highly associated with bone maintenance, and clinical studies provided controversial associations with dairy consumption. We aimed to evaluate the impact of milk extracellular vesicles (mEVs) on the dynamics of bone loss in mice. MEVs are nanoparticles containing proteins, mRNA and microRNA, and were supplemented into the drinking water of mice, either receiving diet-induced obesity or ovariectomy (OVX). Mice receiving mEVs were protected from the bone loss caused by diet-induced obesity. In a more severe model of bone loss, OVX, higher osteoclast numbers in the femur were found, which were lowered by mEV treatment. Additionally, the osteoclastogenic potential of bone marrow-derived precursor cells was lowered in mEV-treated mice. The reduced stiffness in the femur of OVX mice was consequently reversed by mEV treatment, accompanied by improvement in the bone microarchitecture. In general, the RANKL/OPG ratio increased systemically and locally in both models and was rescued by mEV treatment. The number of osteocytes, as primary regulators of the RANKL/OPG system, raised in the femur of the OVX mEVs-treated group compared to OVX nontreated mice. Also, the osteocyte cell line treated with mEVs demonstrated a lowered RANKL/OPG ratio. Thus, mEVs showed systemic and local osteoprotective properties in two mouse models of bone loss reflected in reduced osteoclast presence. Data reveal mEV potential in bone modulation, acting via osteocyte enhancement and RANKL/OPG regulation. We suggest that mEVs could be a therapeutic candidate for the treatment of bone loss.
Assunto: Vesículas extracelulares
Leite
Osteoporose
Obesidade
Osteócitos
Idioma: por
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Instituição: UFMG
Departamento: ENF - DEPARTAMENTO DE NUTRIÇÃO
FAO - DEPARTAMENTO DE ODONTOLOGIA RESTAURADORA
ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA
ICB - DEPARTAMENTO DE FARMACOLOGIA
Tipo de Acesso: Acesso Aberto
Identificador DOI: https://doi.org/10.3389/fbioe.2020.00891
URI: http://hdl.handle.net/1843/53961
Data do documento: 2020
metadata.dc.url.externa: https://www.frontiersin.org/articles/10.3389/fbioe.2020.00891/full
metadata.dc.relation.ispartof: Frontiers in bioengineering and biotechnology
Aparece nas coleções:Artigo de Periódico



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.